Morgan Stanley’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-312,804
| Closed | -$8.46M | – | 8074 |
|
|
2024
Q2 | $8.46M | Sell |
312,804
-1,519,946
| -83% | -$31.6M | ﹤0.01% | 3447 |
|
|
2024
Q1 | $33.6M | Buy |
1,832,750
+106,342
| +6% | +$1.69M | ﹤0.01% | 2137 |
|
|
2023
Q4 | $21.2M | Buy |
1,726,408
+1,155,177
| +202% | +$10.8M | ﹤0.01% | 2624 |
|
|
2023
Q3 | $8.56M | Buy |
571,231
+176,965
| +45% | +$3.68M | ﹤0.01% | 3273 |
|
|
2023
Q2 | $12.8M | Sell |
394,266
-120,461
| -23% | -$4.4M | ﹤0.01% | 2927 |
|
|
2023
Q1 | $20.1M | Buy |
514,727
+201,111
| +64% | +$9.84M | ﹤0.01% | 2408 |
|
|
2022
Q4 | $16.6M | Buy |
313,616
+135,652
| +76% | +$6.61M | ﹤0.01% | 2534 |
|
|
2022
Q3 | $8.01M | Buy |
177,964
+36,979
| +26% | +$1.59M | ﹤0.01% | 3196 |
|
|
2022
Q2 | $5.13M | Buy |
140,985
+71,993
| +104% | +$2.62M | ﹤0.01% | 3734 |
|
|
2022
Q1 | $2.85M | Buy |
68,992
+14,361
| +26% | +$505K | ﹤0.01% | 4243 |
|
|
2021
Q4 | $2.33M | Sell |
54,631
-116,970
| -68% | -$5.85M | ﹤0.01% | 4460 |
|
|
2021
Q3 | $9.45M | Buy |
171,601
+61,644
| +56% | +$3.23M | ﹤0.01% | 2957 |
|
|
2021
Q2 | $5.26M | Sell |
109,957
-27,754
| -20% | -$1.41M | ﹤0.01% | 3727 |
|
|
2021
Q1 | $6.97M | Sell |
137,711
-146,147
| -51% | -$8.12M | ﹤0.01% | 3053 |
|
|
2020
Q4 | $17.9M | Buy |
283,858
+70,242
| +33% | +$4.36M | ﹤0.01% | 1907 |
|
|
2020
Q3 | $14.4M | Buy |
213,616
+16,180
| +8% | +$883K | ﹤0.01% | 1718 |
|
|
2020
Q2 | $8.27M | Buy |
197,436
+184,819
| +1,465% | +$7.1M | ﹤0.01% | 2145 |
|
|
2020
Q1 | $397K | Sell |
12,617
-19,317
| -60% | -$773K | ﹤0.01% | 4513 |
|
|
2019
Q4 | $1.29M | Buy |
31,934
+26,076
| +445% | +$913K | ﹤0.01% | 4358 |
|
|
2019
Q3 | $191K | Sell |
5,858
-5,703
| -49% | -$227K | ﹤0.01% | 5156 |
|
|
2019
Q2 | $561K | Buy |
+11,561
| New | +$492K | ﹤0.01% | 4549 |
|
Other funds holding SILK
Morgan Stanley's SILK Position: Q3 2024 in Review
Morgan Stanley sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 312,804 shares — an estimated $8.46M sold.
Morgan Stanley first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $33.6M in Q1 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Morgan Stanley reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Morgan Stanley sold 312,804 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $8.46M.
- Morgan Stanley first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- Morgan Stanley's Silk Road Medical, Inc. Common Stock position peaked at $33.6M in Q1 2024.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.